Lobbying Pressure Stalls Global Health Policies
The World Health Organization attributes the delay of life-saving health policies to lobbying by tobacco, alcohol, and ultra-processed food industries. As the United Nations prepares to address non-communicable diseases, increased advocacy from these industries challenges efforts to implement effective measures. WHO stresses the urgency of prioritizing public health over commercial interests.

The World Health Organization has raised concerns about the influence of tobacco, alcohol, and ultra-processed food companies in obstructing crucial health policies globally. A report suggests that even a minimal investment in non-communicable diseases could yield significant health and financial benefits if not for industry lobbying.
The WHO notes that governments face substantial lobbying from industries attempting to hinder policies such as health taxes and marketing restrictions targeted at children. This is happening as the UN dedicates its next session to tackling diseases like cancer and heart disease.
Amidst these discussions, industry representatives argue they are open to contributing to the dialogue rather than impeding it. However, health advocacy groups express concerns that political declarations may be diluted under industry pressure, affecting the outcome of essential policy decisions.
(With inputs from agencies.)